Stay updated with breaking news from Collaborative Research Registry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven
Molecular Residual Disease study and multiple RiskScore studies among seven new datasets to be shared by Myriad and Collaborators SALT LAKE CITY, May 23, 2024 -- Myriad Genetics, Inc., , a leader...
SALT LAKE CITY, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. MYGN, a leader in genetic testing and precision medicine, today announced the launch…